window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-108383172-1');

About Sahar Hosseinian

This author has not yet filled in any details.
So far Sahar Hosseinian has created 12 blog entries.

Novigenix-Led Consortium Secures Eurostars Funding to Develop Predictive Immune Checkpoint Inhibitor Test

By |2024-06-17T20:40:00+02:0022 December 2020|Communiqué de presse, News Novigenix|

Total amount up to €1 million awarded to consortium of leading cancer centers and innovative healthcare companies LAUSANNE, SWITZERLAND – 07:00 CET, December 22, 2020 Novigenix SA Switzerland, a pioneer in Immuno-Transcriptomics for precision medicine today announced that a consortium, including PamGene International BV and Radboud University (The Netherlands), has been awarded a grant up to €1 million

Read More

Novigenix presents new Immuno-Transcriptomic data for prediction of response to immunotherapy in metastatic urothelial cancer patients

By |2024-06-17T20:40:57+02:0024 September 2020|Communiqué de presse, News Novigenix|

Newly discovered blood signature presented at ESMO 2020  LAUSANNE, SWITZERLAND – 07:00 CET, September 17th, 2020 – Novigenix SA, a pioneer in Immuno-Transcriptomics for precision oncology, today announced a new Immuno-Transcriptomic signature for predicting response to immunotherapy in metastatic urothelial cancer patients. The data are presented at the European Society for Medical Oncology (ESMO)

Read More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Learn more Ok

Privacy Notice

Go to Top